Sparc Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 3.50 M
as on 01-07-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.31 Cr
as on 01-07-2024
- Revenue 85.39%
(FY 2022)
- Profit 121.54%
(FY 2022)
- Ebitda 91.43%
(FY 2022)
- Net Worth 43.24%
(FY 2022)
- Total Assets 74.37%
(FY 2022)
About Sparc Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.50 M.
The company has closed loans amounting to ₹1.31 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Garima Varma, Gaurav Varma, Govardhan Varma, and One other member serve as directors at the Company.
- CIN/LLPIN
U74110MH2010PTC202085
- Company No.
202085
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sparc Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupama Varma  | Managing Director | 16-Apr-2010 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Varma | Director | 01-Dec-2021 | Current |
| Garima Varma | Director | 01-Dec-2021 | Current |
| Govardhan Varma | Director | 16-Apr-2010 | Current |
Financial Performance of Sparc Biotech.
Sparc Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 85.39% increase. The company also saw a substantial improvement in profitability, with a 121.54% increase in profit. The company's net worth Soared by an impressive increase of 43.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sparc Biotech?
In 2019, Sparc Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Dec 2014 | ₹8.60 M | Satisfied |
Oriental Bank Of Commerce Creation Date: 22 Apr 2010 | ₹4.50 M | Satisfied |
How Many Employees Work at Sparc Biotech?
Unlock and access historical data on people associated with Sparc Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sparc Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparc Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
